BMRN $93.11 -0.78 (-0.83%)
Fri, Dec 14, 2018
BioMarin Pharmaceutical Inc is a Health Care stock that trades on the NASDAQ with a market cap of $9.41 Billion
BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin has a hemophilia A gene therapy and a treatment for achondroplasia in late-stage clinical trials. http://www.bmrn.com
If you haven't signed up for Ebates yet, you are definitely leaving money on the table.
Get up to 12% CASH BACK from shopping @ $AMZN, $WMT and $EBAY & $10 Sign Up Bonus (through this link)!
BioMarin Pharmaceutical Inc Stock Charts
The 5 year and 1 year stock charts are below.
50 Day Moving Average
The 50 Day Moving Average is at $96.89 which is 3.9% above the stock price of $93.11.
200 Day Moving Average
The 200 Day Moving Average is at 93.43 which is 0.34% abovethe stock price of $93.11.
Because both the 50 DMA and 200 DMA are above the current stock price, this can be considered a bearish technical indicator.
BMRN Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $93.11.
The Year To Date (YTD) return is +2.28%.
52 Week Low
The 52 Week Low stock price is $76.01 set on Fri, Apr 6, 2018 which is 254 days ago.
The current price per share is 22.50% above the 52 week low.
52 Week High
The 52 Week High stock price is $106.07 set on Wed, Oct 17, 2018 which is 60 days ago.
The current price per share is -12.22% below the 52 week high.
All Time High
The All Time High stock price is $149.13 set on Mon, Jul 20, 2015 which is 1,245 days ago.
The current price per share is -37.56% below the all time high.
Below is the EPS, P/E Ratio and Earnings Date.
The EPS is -$0.07 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for BioMarin Pharmaceutical Inc was Thu, Aug 2, 2018.
Since this earnings release 136 days ago, the stock price is down by -7.78%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Thu, Oct 25, 2018, which was 52 days ago.
Since this earnings date, the stock price is up by +0.25%.
BioMarin Pharmaceutical Inc Dividend
Below is important Dividend information.
BMRN currently does not pay a dividend.
You may like this list of best dividend stocks of 2018.
Below are some other Biotech & Pharma industry stocks like BioMarin Pharmaceutical Inc.